Antioxidant disclaimers
This article was originally published in The Tan Sheet
Executive Summary
"FDA has determined that although some scientific evidence suggests that consumption of antioxidant vitamins may reduce the risk of certain forms of cancer, this evidence is limited and not conclusive," reads one acceptable disclaimer crafted to accompany antioxidant health claim, agency tells Durk Pearson et al. in April 6 letter. Washington, D.C. federal court Judge Gladys Kessler directed FDA to permit the claim "consumption of antioxidant vitamins may reduce the risk of certain kinds of cancer" in a Dec. 26 opinion (1"The Tan Sheet" Jan. 6, 2003, p. 15). FDA has developed two other similar disclaimers that companies may use when opting to run the new health claim...
You may also be interested in...
FDA Antioxidants/Cancer Risk Reduction Claim Ban Found Unconstitutional
FDA's rejection of an antioxidants/cancer risk reduction health claim fails to satisfy the conditions that permit a ban of the claim because evidence exists supporting the relationship, according to a Dec. 26 Washington, D.C. federal court opinion
Sanofi Clinches Key Phase III Immunology Win With Rilzabrutinib
Sanofi’s BTK inhibitor – one of two from its 2021 Principia buy – passed a Phase III test in immune thrombocytopenia as the company focuses on Dupixent-like blockbusters going forward.
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.